TFX

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applys purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Its portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.
CEO
Employees
14000
Headquarters

550 E Swedesford Rd Ste 400
Wayne, Pennsylvania 19087-1601
Phone: 16102256800
www.teleflex.com

News

Teleflex Incorporated – Consensus Indicates Potential 11.6% Upside
Aug 16, 2022 12:26pm

Teleflex Incorporated with ticker code (TFX) now have 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 370 and 248 with the average target price sitting at 286.82. With the stocks previous close at 256.95 this indicates there is a potential upside of 11.6%. The 50 day moving average now sits at 255.79 and the 200 day MA is 305.43. The market cap for the company is $11,944m. You can visit the company''s website by visiting: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $13,333m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
Teleflex Incorporated – Consensus Indicates Potential 13.1% Upside
Aug 13, 2022 11:48am

Teleflex Incorporated with ticker code (TFX) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 370 and 248 and has a mean target at 286.82. Given that the stocks previous close was at 253.53 this is indicating there is a potential upside of 13.1%. There is a 50 day moving average of 256.51 while the 200 day moving average is 305.99. The company has a market capitalisation of $12,052m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $13,635m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
Teleflex Incorporated – Consensus Indicates Potential 14.5% Upside
Aug 07, 2022 15:00pm

Teleflex Incorporated with ticker code (TFX) now have 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 370 and 248 with a mean TP of 286.82. Now with the previous closing price of 250.56 this indicates there is a potential upside of 14.5%. There is a 50 day moving average of 259.69 and the 200 day MA is 309.02. The market cap for the company is $11,753m. Company Website: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $13,454m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
Teleflex''s Return on Invested Capital Overview
Aug 03, 2022 13:56pm

According to Benzinga Pro, during Q2, Teleflex (NYSE: TFX ) earned $105.51 million, a 36.78% increase from the preceding quarter. Teleflex also posted a total of $704.54 million in sales, a 9.79% increase since Q1. Teleflex earned $77.14 million, and sales totaled $641.72 million in Q1. What Is Return On Invested Capital? Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of a company and is a sign of higher earnings … Full story available on Benzinga.com


Source:Benzinga
Trend Tracker for Invalid Iqfeed Symbol TFX
Aug 02, 2022 15:30pm

Stimulus Matters to the Stock Market and to Invalid Iqfeed Symbol TFX


Source:Stock Traders Daily
Teleflex signs group purchasing deal with Vizient
Aug 01, 2022 11:28am

Teleflex (TFX) has won a contract from Vizient for the supply of Central Venous Access products.The group purchasing agreement includes access to Teleflex Arrowg+ard Blue Plus CVCs…


Source:Seeking Alpha
Teleflex Incorporated – Consensus Indicates Potential 28.3% Upside
Aug 01, 2022 06:36am

Teleflex Incorporated found using ticker (TFX) now have 11 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 430 and 260 and has a mean target at 315.18. Given that the stocks previous close was at 245.69 this now indicates there is a potential upside of 28.3%. The 50 day MA is 263.38 and the 200 day moving average is 311.81. The company has a market capitalisation of $11,279m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $14,469m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
Teleflex downgraded to equal weight at Wells Fargo on slowing UroLift growth
Jul 29, 2022 16:14pm

Wells Fargo has downgraded Teleflex (TFX) from overweight to equal weight as its UroLift System enlarged prostate procedure is showing signsof slowing growth.Analyst Larry Biegelsen…


Source:Seeking Alpha
Teleflex PT Lowered to $370 at JMP Securities
Jul 29, 2022 05:57am

https://www.investing.com/news/pro/teleflex-pt-receives-investment-bank-analyst-rating-update-432SI-2857521


Source:Investing.com
Teleflex, Inc. (TFX) CEO Liam Kelly on Q2 2022 Results - Earnings Call Transcript
Jul 28, 2022 18:34pm

Teleflex, Inc. (NYSE:NYSE:TFX) Q2 2022 Earnings Conference Call July 28, 2022, 08:00 ET Company Participants Lawrence Keusch - VP, IR & Strategy Development Liam Kelly - Chairman,…


Source:Seeking Alpha
Teleflex Shares Fall After Revised FY22 Outlook Lags Consensus
Jul 28, 2022 16:10pm

Teleflex Incorporated (NYSE: TFX ) reported Q2 FY22 revenues of $704.5 million , down 1.3% Y/Y, up 2.3% on a constant currency basis, missing the consensus of $719.50 million. Lower sales from the Interventional Urology segment impacted the … Full story available on Benzinga.com


Source:Benzinga
Teleflex down 8% on lower 2022 guidance, revenue miss
Jul 28, 2022 15:21pm

Teleflex (TFX) is trading down ~8% after the company lowered its 2022 profit guidance and posted Q2 revenue that missed estimates due to slower-than-expected recovery in…


Source:Seeking Alpha
Teleflex: Q2 Earnings Insights
Jul 28, 2022 11:37am

Teleflex (NYSE: TFX ) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:30 AM. Here''s what investors need to know about the announcement. Earnings Teleflex beat estimated earnings by 1.5%, reporting an EPS of $3.39 versus an … Full story available on Benzinga.com


Source:Benzinga
Teleflex declares $0.34 dividend (NYSE:TFX)
Jul 28, 2022 11:10am

Teleflex (TFX) declares $0.34/share quarterly dividend, in line with previous.


Source:Seeking Alpha
Teleflex Announces Quarterly Dividend
Jul 28, 2022 10:45am

WAYNE, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2022, to shareholders of record at the close of business on August 15, 2022. Additional information about Teleflex can be obtained from the company’s website at teleflex.com .


Source:GlobeNewswire
Teleflex Non-GAAP EPS of $3.39 beats by $0.05, revenue of $704.5M misses by $15M (NYSE:TFX)
Jul 28, 2022 10:41am

Teleflex press release (TFX): Q2 Non-GAAP EPS of $3.39 beats by $0.05.Revenue of $704.5M (-1.3% Y/Y) misses by $15M.Reducing GAAP and constant currency revenue growth guidance…


Source:Seeking Alpha
Teleflex Reports Second Quarter Financial Results And Full Year Outlook
Jul 28, 2022 10:30am

WAYNE, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 26, 2022.


Source:GlobeNewswire
Teleflex Q2 2022 Earnings Preview
Jul 27, 2022 16:31pm

Teleflex (TFX) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open.The consensus EPS Estimate is $3.34 (-0.3% Y/Y) and the consensus Revenue Estimate…


Source:Seeking Alpha
Teleflex Incorporated – Consensus Indicates Potential 27.1% Upside
Jul 24, 2022 14:58pm

Teleflex Incorporated found using ticker (TFX) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 430 and 270 and has a mean target at 339.82. Given that the stocks previous close was at 267.32 this would indicate that there is a potential upside of 27.1%. There is a 50 day moving average of 265.6 and the 200 moving average now moves to 314.53. The company has a market cap of $12,437m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $15,810m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
Teleflex Announces Second Quarter 2022 Earnings Conference Call Information
Jul 14, 2022 10:30am

WAYNE, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 28, 2022.


Source:GlobeNewswire
Teleflex Incorporated – Consensus Indicates Potential 36.0% Upside
Jul 10, 2022 11:51am

Teleflex Incorporated with ticker code (TFX) now have 11 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 430 and 295 with the average target price sitting at 348. Now with the previous closing price of 255.92 this would indicate that there is a potential upside of 36.0%. The day 50 moving average is 271.98 and the 200 moving average now moves to 321.14. The market capitalisation for the company is $11,944m. Company Website: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $16,241m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
How does current sensing work? 
Jul 05, 2022 00:00am

Current sensing and measurement are important in applications such as power conversion, battery charging, and industrial processes. Different current sensing technologies are used, depending on whether the measurement is for alternating current (AC) or direct current (DC) and how much current needs to be measured. This FAQ reviews Hall effect, and induction sensing and resistive […]


Source:WTWH
Teleflex Incorporated – Consensus Indicates Potential 43.5% Upside
Jul 04, 2022 10:38am

Teleflex Incorporated with ticker code (TFX) now have 10 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 430 and 295 calculating the mean target price we have 352.8. Given that the stocks previous close was at 245.85 this would indicate that there is a potential upside of 43.5%. There is a 50 day moving average of 277.75 and the 200 day MA is 323.71. The company has a market cap of $11,964m. You can visit the company''s website by visiting: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,168m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.


Source:DirectorsTalk
Micron, Kohl''s fall; NextEra, Teleflex rise
Jul 01, 2022 20:31pm

Stocks that traded heavily or had substantial price changes Friday: Micron, Kohl’s fall; NextEra, Teleflex rise


Source:ABC News
Teleflex'' Urolift System shows positive data in five studies to treat enlarged prostate
Jul 01, 2022 12:55pm

Teleflex (TFX) said results from several research studies showed the safety and efficacy of its product, UroLift System, to treat men with enlarged prostate. The company said…


Source:Seeking Alpha
New Data Reinforce Efficacy of the UroLift System for the Treatment of Enlarged Prostate
Jul 01, 2022 10:30am

Presentations at the 37th Annual European Association of Urology Congress to Demonstrate Measurable and Sustained Improvement of BPH Symptoms and IPSS Scores WAYNE, Pa., July 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the results of several research studies that further support the safety and efficacy of the


Source:Wallstreet:Online
Key factors to optimize power consumption in an embedded device
Jul 01, 2022 00:00am

In the previous article, we learned what a low-power system is so now we’ll talk about the key factors using which we can make power-efficient embedded system design. The power-efficient embedded system is comprised of hardware and software design along with proper components selection. Optimization is achieved by efficient implementation in different stages using different…


Source:WTWH
What is a low power design?
Jun 29, 2022 00:00am

Low power design is a system using a collection of techniques and methodologies for the purpose of optimizing battery life and reducing the overall power dissipation of the system. To optimize the power there are many low power techniques that depend on the level of the design selected, ranging from semiconductor technology to the higher…


Source:WTWH
R&D 100 winner of the day: Guardiant
Jun 29, 2022 00:00am

Corning’s Guardiant is an antimicrobial additive that can be dosed into paints and coatings. Testing performed at the University of Arizona’s microbiology lab show that coatings containing Corning Guardiant can kill 99.9% of germs on coated surfaces, including the virus that causes COVID-19 within two hours. Guardiant uses Corning’s expertise in glass ceramic technology, allowing…


Source:WTWH
Fluid Power Hall of Fame adds two new inductees for 2022
Jun 29, 2022 00:00am

The International Fluid Power Society announced its Fluid Power Hall of Fame Class of 2022. The Hall of Fame recognizes those individuals — innovators, researchers, application engineers, educators, as well as sales and service personnel —  who have dedicated their careers, and have made significant contributions to fluid power technology. This year’s class includes two…


Source:WTWH
Things To Consider Before Buying Teleflex Incorporated (NYSE: TFX)
Jun 25, 2022 15:00pm

Teleflex Incorporated (NYSE:TFX) shares, rose in value on Friday, 06/24/22, with the stock price up by 2.61% to the previous day’s close as strong demand from buyers drove the stock to $258.05. Actively observing the price movement in the last trading, the stock closed the session at $251.49, falling within a range of $250.37 and … Things To Consider Before Buying Teleflex Incorporated (NYSE: TFX) Read More »


Source:Stocks Register
Intrommune extends scope of Phase 1 trial for peanut-allergy-treating toothpaste
Jun 22, 2022 00:00am

The food-allergy-focused biotech Intrommune Therapeutics is announcing that it is extending the duration of the ongoing Phase 1 OMEGA clinical trial of INT301 in adults with peanut allergy. The alteration will lengthen the study duration to 48 weeks to include a maintenance period. The study duration was previously 26 weeks. The New York City–based company…


Source:WTWH
Object detection and tracking software accelerates thermal camera integration for ADAS and AV
Jun 22, 2022 00:00am

Teledyne FLIR, part of Teledyne Technologies Incorporated, has announced the release of Prism AI, a software framework that provides classification, object detection and object tracking, enabling perception engineers to quickly start integrating thermal cameras for advanced driver assistance systems (ADAS) and autonomous vehicle (AV) systems. Built for automotive perception system developers, Prism includes features such…


Source:WTWH
Intrommune extends scope of Phase 1 peanut allergy trial 
Jun 22, 2022 00:00am

The food-allergy-focused biotech Intrommune Therapeutics is announcing that it is extending the duration of the ongoing Phase 1 OMEGA clinical trial of INT301 in adults with peanut allergy. The alteration will lengthen the study duration to 48 weeks to include a maintenance period. The study duration was previously 26 weeks. The New York City–based company…


Source:WTWH
Teleflex enrolls first patient in vascular closure device study
Jun 22, 2022 00:00am

Teleflex (NYSE:TFX) announced today that it enrolled the first patient in a clinical study of its Manta vascular closure device. In the study, Wayne, Pennsylvania-based Teleflex intends to demonstrate the safety of Manta ultrasound-guided closure without dependence on the pre-procedural depth locator measurements. According to a news release, the study will enroll up to 150 […]


Source:WTWH
Metaverse Enterprise Solution Market 2022 Size, Share, Global Industry Analysis, Strategic Assessment, Development Status, Upcoming Trends and Forecast Report by 2028
Jun 21, 2022 20:33pm

Metaverse Enterprise Solution Market Trends 2022| Major Key Players Analysis Involve in This Report are Villains, TFX, Veritone, Tumblr and many more with Latest Technological Advancement Report by 2028 Londan, United kingdom -- ( SBWIRE ) -- 06/21/2022 -- Metaverse Enterprise Solution study provides a comprehensive overview of the elements that will likely influence future growth or lack thereof, as well as future prospects and current trends, for the global market as a whole. Demand estimates, market trends, market share, and micro and macro statistics are all examined in depth in this study. The Metaverse Enterprise Solution market study includes a complete analysis of market competition and their profiles. Production capacity, ever-increasing demand, sales, and future growth potential are all examined in the market research. Get a Sample Report of Metaverse Enterprise Solution Market @ https://www.intelligencemarketreport.com/report-sample/609115 To keep readers up to date with technologically evolving markets, the study use modern ways to collect and analyze crucial primary and secondary research data and ideas.


Source:SBWire